However, FOXA1 is sufficient for ER chromatin occupancy and activation of breast cancer signature genes in non-breast cancer cells that typically have low/undetectable FOXA1 expression (i.e., osteosarcoma cells) [38]. This evidence concerns the gene FOXA1 and osteosarcoma.